Bethany Dudek Joins Arcutis as Vice President of Quality

WESTLAKE VILLAGE, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Bethany Dudek has joined the company as Vice President of Quality. As the Arcutis Quality head, Ms. Dudek will be responsible for all aspects of quality as the Company prepares for the potential future commercialization of its product candidates.